(Q38256603)

1 September 2017

1 reference

title

Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma (English)

1 reference

Human T-lymphotropic virus 1

1 September 2017

main subject

0 references

1 reference

Kenji Ishitsuka

1

1 reference

1 September 2017

Kazuo Tamura

series ordinal

2

1 reference

1 September 2017

language of work or name

1 reference

1 October 2014

1 reference

Lancet Oncology Commission

1 September 2017

published in

1 reference

1 September 2017

volume

15

1 reference

1 September 2017

issue

11

1 reference

1 September 2017

page(s)

e517-26

1 reference

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Adult T-cell leukemia: a review of epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Global epidemiology of HTLV-I infection and associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

An HTLV-I vaccine: why, how, for whom?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Epidemiological Aspects and World Distribution of HTLV-1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Current prevalence of HTLV-1 in Japan as determined by screening of blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Blood safety strategies for human T-cell lymphotropic virus in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

The outcome of donor screening for human T-cell lymphotropic virus infection in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

High incidence of human type-C retrovirus (HTLV) in family members of a HTLV-positive Japanese T-cell leukemia patient

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

A Retrospective Study on Transmission of Adult T Cell Leukemia Virus by Blood Transfusion: Seroconversion in Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Mother-to-child transmission of human T-cell lymphotropic virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Regulatory T-cell function of adult T-cell leukemia/lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Expression of functional lung resistance--related protein predicts poor outcome in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Long-term study of indolent adult T-cell leukemia-lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Treatment of adult T-cell leukemia/lymphoma: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970202-5

7 January 2021

10.1016/S1470-2045(14)70202-5

Identifiers

DOI

1 reference

1 September 2017

1 reference